GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » GE HealthCare Technologies Inc (NAS:GEHC) » Definitions » EV-to-EBIT

GE HealthCare Technologies (GE HealthCare Technologies) EV-to-EBIT

: 15.89 (As of Today)
View and export this data going back to 2022. Start your Free Trial

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, GE HealthCare Technologies's Enterprise Value is $46,139 Mil. GE HealthCare Technologies's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $2,903 Mil. Therefore, GE HealthCare Technologies's EV-to-EBIT for today is 15.89.

The historical rank and industry rank for GE HealthCare Technologies's EV-to-EBIT or its related term are showing as below:

GEHC' s EV-to-EBIT Range Over the Past 10 Years
Min: 9.81   Med: 15.36   Max: 17.41
Current: 15.89

During the past 5 years, the highest EV-to-EBIT of GE HealthCare Technologies was 17.41. The lowest was 9.81. And the median was 15.36.

GEHC's EV-to-EBIT is ranked better than
56.07% of 428 companies
in the Healthcare Providers & Services industry
Industry Median: 18.24 vs GEHC: 15.89

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. GE HealthCare Technologies's Enterprise Value for the quarter that ended in Dec. 2023 was $42,753 Mil. GE HealthCare Technologies's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $2,903 Mil. GE HealthCare Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 6.79%.


GE HealthCare Technologies EV-to-EBIT Historical Data

The historical data trend for GE HealthCare Technologies's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GE HealthCare Technologies Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
- - - 13.06 14.73

GE HealthCare Technologies Quarterly Data
Dec19 Dec20 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.06 16.47 16.22 13.26 14.73

Competitive Comparison

For the Health Information Services subindustry, GE HealthCare Technologies's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GE HealthCare Technologies EV-to-EBIT Distribution

For the Healthcare Providers & Services industry and Healthcare sector, GE HealthCare Technologies's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where GE HealthCare Technologies's EV-to-EBIT falls into.



GE HealthCare Technologies EV-to-EBIT Calculation

GE HealthCare Technologies's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=46138.650/2903
=15.89

GE HealthCare Technologies's current Enterprise Value is $46,139 Mil.
GE HealthCare Technologies's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2,903 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GE HealthCare Technologies  (NAS:GEHC) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

GE HealthCare Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=2903/42753.04344
=6.79 %

GE HealthCare Technologies's Enterprise Value for the quarter that ended in Dec. 2023 was $42,753 Mil.
GE HealthCare Technologies's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2,903 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GE HealthCare Technologies EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of GE HealthCare Technologies's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


GE HealthCare Technologies (GE HealthCare Technologies) Business Description

Traded in Other Exchanges
Address
500 West Monroe Street, Chicago, IL, USA, 60661
GE HealthCare Technologies Inc is a globally medical technology, pharmaceutical diagnostics, and digital solutions innovator company. It has four operating segments; Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). It earns a majority of its revenue from the Imaging segment.
Executives
Kevin Michael O'neill officer: CEO, PDx 500 W. MONROE STREET, CHICAGO IL 60661
Roland Rott officer: CEO, Ultrasound 500 W. MONROE STREET, CHICAGO IL 60661
James Saccaro officer: Chief Financial Officer ONE BAXTER PARKWAY, DEERFIELD IL 60015
Jan Makela officer: CEO, Imaging 500 W. MONROE STREET, CHICAGO IL 60661
Taha Kass-hout officer: Chief Technology Officer 500 W. MONROE STREET, CHICAGO IL 60661
Kenneth R. Stacherski officer: Ch. Supply Chain & Serv. Ofc. 500 W MONROE, CHICAGO IL 60661
Culp H Lawrence Jr director GENERAL ELECTRIC COMPANY, ONE FINANCIAL CENTER, SUITE 3700, BOSTON MA 02111
William J Stromberg director 100 E. PRATT STREET, BALTIMORE MD 21202
Thomas J. Westrick officer: CEO, Patient Care Solutions 500 W. MONROE STREET, CHICAGO IL 60661
Yang Watkin Phoebe L. director C/O DOXIMITY, INC., 500 THIRD STREET, SAN FRANCISCO CA 94107
Rodney F Hochman director 21919 30TH DR SE, BOTHELL WA 98021
Tomislav Mihaljevic director ONE FINANCIAL CENTER, SUITE 3700, BOSTON MA 02111
Lloyd Jr Howell director 8283 GREENSBORO DRIVE, MCLEAN VA 22102
Anne T Madden director C/O HONEYWELL 300 S. TRYON STREET, CHARLOTTE NC 28202
Frank R Jimenez officer: GC & Corporate Secretary GE HEALTHCARE TECHNOLOGIES INC., 500 W. MONROE ST., CHICAGO IL 606061